11
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Hepatocyte ABCA1 deletion impairs liver insulin signaling and lipogenesis

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Summary

          Plasma membrane (PM) free cholesterol (FC) is emerging as an important modulator of signal transduction. Here, we show that hepatocyte-specific knockout (HSKO) of the cellular FC exporter, ATP binding cassette transporter A1 (ABCA1), leads to decreased PM FC content and defective trafficking of lysosomal FC to the PM. Chow-fed HSKO mice had reduced hepatic: 1) insulin-stimulated Akt phosphorylation, 2) activation of the lipogenic transcription factor Sterol Regulatory Element Binding Protein (SREBP)-1c, and 3) lipogenic gene expression, versus controls. Consequently, Western-type diet-fed HSKO mice were protected from steatosis. Surprisingly, HSKO mice had intact glucose metabolism; they showed normal gluconeogenic gene suppression in response to re-feeding and normal glucose and insulin tolerance. We conclude that: 1) ABCA1 maintains optimal hepatocyte PM FC, through intracellular FC trafficking, for efficient insulin signaling; and 2) hepatocyte ABCA1 deletion produces a form of selective insulin resistance, such that lipogenesis is suppressed but glucose metabolism remains normal.

          Graphical abstract

          Related collections

          Author and article information

          Journal
          101573691
          39703
          Cell Rep
          Cell Rep
          Cell reports
          2211-1247
          22 May 2017
          06 June 2017
          06 June 2018
          : 19
          : 10
          : 2116-2129
          Affiliations
          [1 ]Department of Internal Medicine/Sections on Molecular Medicine, Winston-Salem, NC 27157
          [2 ]Nephrology, Wake Forest School of Medicine, Winston-Salem, NC 27157
          [3 ]Department of Biochemistry, Wake Forest School of Medicine, Winston-Salem, NC 27157
          [4 ]Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599
          [5 ]Curriculum in Genetics and Molecular Biology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599
          [6 ]Department of Nutrition and Health Sciences, University of Nebraska, Lincoln, NE 68588
          [7 ]Integrative Metabolism Program, Sanford Burnham Prebys Medical Discovery Institute, Orlando, FL 32827
          [8 ]Division of Endocrinology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02062
          Author notes
          [* ] Lead Contact- John S. Parks, PhD, John S. Parks, PhD, Department of Internal Medicine-Section on Molecular Medicine, Wake Forest School of Medicine, Medical Center Blvd, Winston-Salem, NC 27157, jparks@ 123456wakehealth.edu ; phone- 336-716-2145
          [9]

          Present affiliation: Department of Biomedical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY

          Article
          PMC5512440 PMC5512440 5512440 nihpa878104
          10.1016/j.celrep.2017.05.032
          5512440
          28591582
          55d9c8d5-2b85-4014-b78f-cccb090cf3e1
          History
          Categories
          Article

          Comments

          Comment on this article